| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Apellis Pharmaceuticals IncAPLS | +129.35% | $17.89 | $41.03 | 2026-03-18 - 2026-05-15 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +92.36% | $21.33 | $41.03 | 2026-01-13 - 2026-05-15 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +78.78% | $22.95 | $41.03 | 2025-08-01 - 2026-05-15 | Strong Buy |
Xencor IncXNCR | +68.45% | $11.79 | $19.86 | 2025-10-06 - 2026-07-27 | Strong Buy |
Xencor IncXNCR | +41.86% | $14.00 | $19.86 | 2025-11-06 - 2026-07-27 | Strong Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eyepoint IncEYPT | 1 | Strong Buy | $47.00 | +278.73% | Assumes | 20 days ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $20.00 | +390.20% | Initiates Coverage On | 2 months ago |
Harrow IncHROW | 3 | Strong Buy | $88.00 | +134.92% | Maintains | 3 months ago |
Inflarx NvIFRX | 1 | Strong Buy | $4.00 | +135.29% | Maintains | 3 months ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $7.00 | +33.33% | Initiates Coverage On | 3 months ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $100.00 | +186.78% | Maintains | 3 months ago |
Opus Genetics IncIRD | 1 | Strong Buy | $15.00 | +347.76% | Initiates Coverage On | 4 months ago |
Surrozen IncSRZN | 2 | Strong Buy | $40.00 | +101.92% | Reiterates | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 3 | Strong Buy | $31.00 | -24.45% | Maintains | 4 months ago |
Korro Bio IncKRRO | 2 | Strong Buy | $22.00 | +105.22% | Maintains | 5 months ago |
Belite Bio IncBLTE | 2 | Strong Buy | $266.00 | +67.90% | Maintains | 5 months ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $41.00 | +592.57% | Maintains | 6 months ago |
Xencor IncXNCR | 2 | Strong Buy | $42.00 | +111.48% | Maintains | 9 months ago |
Innoviva IncINVA | 2 | Strong Buy | $31.00 | +45.54% | Maintains | 9 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Strong Buy | $7.00 | +104.68% | Initiates Coverage On | 10 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $52.00 | N/A | Initiates Coverage On | a year ago |